205 related articles for article (PubMed ID: 29851855)
1. Prognostic values of abdominal body compositions on survival in advanced pancreatic cancer.
Bian X; Dai H; Feng J; Ji H; Fang Y; Jiang N; Li W
Medicine (Baltimore); 2018 Jun; 97(22):e10988. PubMed ID: 29851855
[TBL] [Abstract][Full Text] [Related]
2. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
[TBL] [Abstract][Full Text] [Related]
3. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.
Nakano O; Kawai H; Kobayashi T; Kohisa J; Ikarashi S; Hayashi K; Yokoyama J; Terai S
Cancer Med; 2021 Jul; 10(13):4291-4301. PubMed ID: 33993635
[TBL] [Abstract][Full Text] [Related]
4. Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation.
Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yagi S; Kamo N; Okajima H; Uemoto S
Transplantation; 2017 Mar; 101(3):565-574. PubMed ID: 27926595
[TBL] [Abstract][Full Text] [Related]
5. Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Fujimoto Y; Iida T; Yagi S; Taura K; Hatano E; Okajima H; Uemoto S
Ann Surg Oncol; 2017 Apr; 24(4):1037-1045. PubMed ID: 27837297
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
7. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis.
Ebadi M; Tandon P; Moctezuma-Velazquez C; Ghosh S; Baracos VE; Mazurak VC; Montano-Loza AJ
J Hepatol; 2018 Sep; 69(3):608-616. PubMed ID: 29709682
[TBL] [Abstract][Full Text] [Related]
8. The clinical impact of preoperative body composition differs between male and female colorectal cancer patients.
Tokunaga R; Nakagawa S; Miyamoto Y; Ohuchi M; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Yoshida N; Baba H
Colorectal Dis; 2020 Jan; 22(1):62-70. PubMed ID: 31344314
[TBL] [Abstract][Full Text] [Related]
9. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
10. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
Vrieling A; Kampman E; Knijnenburg NC; Mulders PF; Sedelaar JPM; Baracos VE; Kiemeney LA
Eur Urol Focus; 2018 Apr; 4(3):420-434. PubMed ID: 28753824
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of initial and longitudinal changes in body composition in metastatic pancreatic cancer.
Lee MW; Jeon SK; Paik WH; Yoon JH; Joo I; Lee JM; Lee SH
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):735-745. PubMed ID: 38332658
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular and abdominal fat measured by computed tomography and mortality of hemodialysis patients.
Kojima S; Usui N; Shigetake M; Uehata A; Inatsu A; Ando S; Matsuzawa R; Suzuki Y; Nakata J; Tsuchiya T; Hisadome H; Mawatari T; Tsubaki A
Nephrol Dial Transplant; 2024 Jan; 39(2):286-296. PubMed ID: 37458763
[TBL] [Abstract][Full Text] [Related]
14. Preoperative skeletal muscle index and visceral-to-subcutaneous fat area ratio are associated with long-term outcomes of elderly gastric cancer patients after gastrectomy.
Taki Y; Sato S; Nakatani E; Higashizono K; Nagai E; Nishida M; Watanabe M; Ohata K; Kanemoto H; Oba N
Langenbecks Arch Surg; 2021 Mar; 406(2):463-471. PubMed ID: 33515316
[TBL] [Abstract][Full Text] [Related]
15. Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.
Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
World J Surg; 2018 Apr; 42(4):1180-1191. PubMed ID: 28936708
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia as a Predictor of Survival in Patients with Pancreatic Adenocarcinoma After Pancreatectomy.
Rom H; Tamir S; Van Vugt JLA; Berger Y; Perl G; Morgenstern S; Tovar A; Brenner B; Benchimol D; Kashtan H; Sadot E
Ann Surg Oncol; 2022 Mar; 29(3):1553-1563. PubMed ID: 34716836
[TBL] [Abstract][Full Text] [Related]
17. Influence of skeletal muscle and intermuscular fat on postoperative complications and long-term survival in rectal cancer patients.
Nie T; Wu F; Heng Y; Cai W; Liu Z; Qin L; Cao Y; Zheng C
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):702-717. PubMed ID: 38293722
[TBL] [Abstract][Full Text] [Related]
18. Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer.
Lee J; Lee JC; Kim HW; Kim J; Hwang JH
PLoS One; 2020; 15(9):e0238649. PubMed ID: 32936836
[TBL] [Abstract][Full Text] [Related]
19. Visceral adiposity is an independent risk factor for high intra-operative blood loss during living-donor liver transplantation; could preoperative rehabilitation and nutritional therapy mitigate that risk?
Macshut M; Kaido T; Yao S; Miyachi Y; Sharshar M; Iwamura S; Hirata M; Shirai H; Kamo N; Yagi S; Uemoto S
Clin Nutr; 2021 Mar; 40(3):956-965. PubMed ID: 32665100
[TBL] [Abstract][Full Text] [Related]
20. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
